ferumoxytol


( Last Updated : August 3, 2022)
Generic Name:
ferumoxytol
Project Status:
Pending
Therapeutic Area:
Iron deficiency anemia
Manufacturer:
Covis Pharma Canada Ltd.
Call for patient/clinician input open:
Brand Name:
TBC
Project Line:
Reimbursement Review
Project Number:
SR0753-000
Call for patient/clinician input closed:

Details


Manufacturer Requested Reimbursement Criteria1:
For the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron.
Submission Type:
Initial
Fee Schedule:
Pending
Indications:
For the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron.
Anticipated Date:
  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.